Groowe Groowe / Newsroom / AMGN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AMGN News

Amgen Inc

Top 10 Great Reasons to Visit Velocity Invitational at Sonoma Raceway This Weekend!

globenewswire.com
TSLA GM RACE PAG HOG F VWAGY RIVN LCID NIO XPEV WKHS HYMC CHPT EVGO BLNK PSNY PGR GE GOOG META AMZN MSFT NVDA AMD INTC QCOM MU AMAT ASML LRCX KLAC TER ADI NXPI ON MCHP AEHR ENPH SEDG PLUG FCEL BE BALL CPRT CAR AZZ ALGN BIIB REGN GILD AMGN BMY MRK PFE JNJ ABBV AZN SNOW DDOG CRWD PANW FTNT OKTA SMCI CRIS EDIT BEAM NTLA BNTX MRNA COIN PYPL MP PLTR AI UPST SOFI HOOD ETSY MELI BABA JD NFLX DIS CMCSA EA TTWO RBLX

AI Supercomputing Platform Market Research 2026-2032: Competition Intensifies as NVIDIA Leads While AMD, Intel and Hyperscalers Expand Custom Silicon Strategies

globenewswire.com
NVDA AMD INTC HPE DELL MSFT AMZN GOOG ORCL SMCI MU META TSM BRO CSCO IBM ARM AMAT LRCX KLAC QCOM CRSP REGN GILD BMY MRNA BIIB EXAS ILMN VRTX AZN PFE JNJ AMGN LLY ABBV BKR XOM CVX NEE DUK SO ED PCG SRE AEP WEC ETR NI XEL NRG CEG EIX FE D CMS PNW ES

Ember LifeSciences announces new strategic investments boosting Series A to $27M

prnewswire.com
AMGN

CGRP Inhibitors Market to Reach US$12.5 Bn by 2033 Expands with Rising Migraine Awareness and Advanced Targeted Therapies - Persistence Market Research

prnewswire.com
AMGN LLY TEVA PFE ABBV

Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline

globenewswire.com
AMGN

Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

globenewswire.com
SNGX IPHA BMY NKTX AZN MRK TAK NVS GMAB ABBV BIIB CRSP INCY ALKS PFE REGN GILD AMGN

Late-Stage Chronic Kidney Disease Market Analysis Report 2026-2036, Profiles of Key Players - Novartis, Merck & Co, Pfizer, Sanofi, and Johnson & Johnson

globenewswire.com
AMGN FMS DVA ABBV NVS MRK PFE SNY JNJ

Chronic Gout Market Research Report 2026-2036 - Late-stage Pipeline, Including SEL-212 and Dapansutrile Signals a New Wave of Therapies

globenewswire.com
AMGN

Form 8-K

sec.gov
AMGN

Acute Myocardial Infarction Market is Expected to Hit Growth Stride at a CAGR of 13% During the Forecast Period (2026-2036) with New Therapeutic Innovations | DelveInsight

prnewswire.com
NVO BMY JNJ AMGN REGN SNY PFE AZN LLY NVS